Westhampton Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$254K Hold
1,975
0.11% 113
2026
Q1
$238K Hold
1,975
0.11% 114
2025
Q4
$208K Buy
+1,975
New +$185K 0.1% 119
2025
Q1
Sell
-5,410
Closed -$538K 120
2024
Q4
$538K Sell
5,410
-100
-2% -$10.3K 0.27% 85
2024
Q3
$626K Hold
5,510
0.32% 83
2024
Q2
$682K Sell
5,510
-102
-2% -$13.1K 0.37% 74
2024
Q1
$740K Buy
5,612
+1
+0% +$123 0.4% 72
2023
Q4
$612K Sell
5,611
-445
-7% -$46.2K 0.36% 79
2023
Q3
$623K Buy
+6,056
New +$653K 0.4% 75
2023
Q2
Sell
-5,505
Closed -$586K 122
2023
Q1
$586K Buy
5,505
+50
+0.9% +$5.4K 0.38% 75
2022
Q4
$605K Buy
5,455
+650
+14% +$66.4K 0.41% 74
2022
Q3
$414K Hold
4,805
0.31% 85
2022
Q2
$438K Hold
4,805
0.31% 88
2022
Q1
$394K Hold
4,805
0.25% 93
2021
Q4
$368K Hold
4,805
0.23% 93
2021
Q3
$361K Sell
4,805
-2,100
-30% -$160K 0.25% 91
2021
Q2
$537K Sell
6,905
-227
-3% -$16.9K 0.35% 80
2021
Q1
$525K Buy
7,132
+53
+0.7% +$3.91K 0.36% 76
2020
Q4
$553K Sell
7,079
-598
-8% -$45.7K 0.41% 66
2020
Q3
$608K Buy
7,677
+37
+0.5% +$2.9K 0.5% 58
2020
Q2
$564K Sell
7,640
-288
-4% -$21.7K 0.49% 61
2020
Q1
$582K Buy
7,928
+1,153
+17% +$90.6K 0.6% 51
2019
Q4
$588K Hold
6,775
0.48% 61
2019
Q3
$544K Hold
6,775
0.46% 60
2019
Q2
$542K Buy
+6,775
New +$519K 0.46% 62

Other funds holding MRK

Westhampton Capital's MRK Position: Q2 2026 in Review

Westhampton Capital held its Merck (MRK) position steady in Q2 2026 at 1,975 shares worth $254K. The position accounts for 0.11% of the portfolio, ranked #113.

Westhampton Capital first reported a position in MRK in Q2 2019 and has held it in 25 quarters since. The position peaked at $740K in Q1 2024. 1,410 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Westhampton Capital held 1,975 shares of Merck worth $254K as of Q2 2026.
  • Westhampton Capital left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.11% of Westhampton Capital's portfolio in Q2 2026, its #113 holding.
  • Westhampton Capital first reported a position in Merck in Q2 2019 and has held it in 25 quarters since.
  • Westhampton Capital's Merck position peaked at $740K in Q1 2024.
  • 1,410 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Westhampton Capital's 13F filing for Q2 2026, filed 14 Jul 2026.